ATS 2022 International Conference News Preview - 5

MONDAY, MAY 16, 2022
Dinner Service: 6:30 PM - 7:00 PM | Panel Discussions + Experienced Patient with NCFBE: 7:00 PM
InterContinental San Francisco
Grand Ballroom
Register Now!
www.rmei.com/ATS2022
- 8:30 PM
PRACTICAL CONSIDERATIONS FOR RECOGNIZING, DIAGNOSING, AND MANAGING
NON-CYSTIC FIBROSIS BRONCHIECTASIS
A SATELLITE SYMPOSIUM DURING THE ATS 2022 INTERNATIONAL CONFERENCE
Join us for this in-person CME event, where Drs. Addrizzo-Harris, O'Donnell, and Daley share clinical pearls for the
diagnosis and treatment of non-cystic fibrosis bronchiectasis (NCFBE) and a novel emerging treatment targeting the
neutrophilic inflammation present in NCFBE.
Joining the panel will be an experienced patient with NCFBE sharing teaching moments about the personal impact of
this disease and goals of care.
FACULTY
Doreen J. Addrizzo-Harris,
MD (Chair)
NYU Grossman School of Medicine
CHAIR & PANELIST
Charles L. Daley, MD
National Jewish Health
SPEAKER & PANELIST
Anne E. O'Donnell, MD
Georgetown University Medical Center
SPEAKER & PANELIST
Joint Accreditation Statement
In support of improving patient care, RMEI Medical Education, LLC is jointly
accredited by the Accreditation Council for Continuing Medical Education
(ACCME), the Accreditation Council for Pharmacy Education (ACPE), and
the American Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be better able to:
* Apply current criteria for diagnosing non-cystic fibrosis bronchiectasis (NCFBE)
* Employ current management strategies for the treatment of patients with NCFBE
* Examine the role of neutrophil serine proteases (NSPs) in the pathophysiology
of NCFBE
* Assess the potential impact of emerging therapies targeting NSPs on the
treatment of NCFBE
WHO SHOULD ATTEND?
This activity is intended for pulmonary, infectious diseases, radiology, and primary
care clinicians who manage patients with non-cystic fibrosis bronchiectasis (NCFBE).
FEE & REGISTRATION INFORMATION
There is no fee for this educational activity. For more information and to register,
visit www.rmei.com/ATS2022
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc).
Please contact RMEI prior to the live event at contact@rmei.com.
PROVIDER STATEMENT
This activity is provided by RMEI Medical Education, LLC.
SUPPORTER STATEMENT
This activity is supported by an educational grant from Insmed.
A MECC-ORGANIZED SYMPOSIUM AT THE ATS 2022 INTERNATIONAL CONFERENCE
AN EVENING SYMPOSIA EDUCATIONAL PROGRAM PROVIDED BY RMEI MEDICAL EDUCATION, LLC AND SUPPORTED BY AN EDUCATIONAL GRANT FROM INSMED OPEN TO ALL ATS 2022 INTERNATIONAL CONFERENCE ATTENDEES.

http://www.rmei.com/ATS2022

ATS 2022 International Conference News Preview

Table of Contents for the Digital Edition of ATS 2022 International Conference News Preview